Stock Events

Stock Events

BioNexus Gene Lab 

$1.5700
24
+$0.03+1.95% Wednesday 20:00
+$0.00+0%Wednesday 22:45After hours

Statistics

Day High
1.655
Day Low
1.57
52W High
6.1
52W Low
1.07
Volume
5,584
Avg. Volume
-
Mkt Cap
3.8M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
0
0.01
0.01
Expected EPS
N/A
Actual EPS
0.0017

Financials

-40.2%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.43MRevenue
-2.99MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLC. It's not an investment recommendation.
Apple
5
AAPL
Microsoft
5
MSFT
Amazon
5
AMZN
NVIDIA
5
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap28.82B
Illumina provides integrated sequencing and array-based solutions for genetic and genomic analysis, directly competing in the gene sequencing space with BioNexus Gene Lab.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics is involved in gene editing, a direct competitor in the genetic engineering and modification sector, offering alternative or complementary technologies to those of BioNexus Gene Lab.
Intellia Therapeutics
NTLA
Mkt Cap1.67B
Intellia Therapeutics is a leading genome editing company that competes with BioNexus Gene Lab in the development of therapeutics based on gene editing technologies.
Editas Medicine
EDIT
Mkt Cap433.1M
Editas Medicine operates in the CRISPR gene editing space, making it a competitor by offering gene editing technologies and therapies that may overlap with or rival those of BioNexus Gene Lab.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences offers long-read sequencing technologies, competing with BioNexus Gene Lab in the genomic analysis and sequencing market.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals is involved in genetic sequencing and the development of medications based on genetic insights, positioning it as a competitor in the genetic research and therapeutic development space.
Vertex Pharmaceuticals
VRTX
Mkt Cap128.19B
Vertex Pharmaceuticals engages in the creation of drugs based on genetic insights, making it a competitor in the field of genetic disease treatment and research.
Teladoc Health
TDOC
Mkt Cap1.24B
Teladoc Health, through its acquisition of Livongo and other initiatives, is expanding into the genetic health advice and telemedicine space, indirectly competing with BioNexus Gene Lab's genetic analysis services.
Guardant Health
GH
Mkt Cap21.1B
Guardant Health specializes in cancer diagnostics through liquid biopsies, competing in the genetic testing market, particularly in the oncology segment.

About

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Show more...
CEO
Su-Leng Tan
Employees
1
Country
Malaysia
ISIN
US0906283066

Listings

XNAS
US
BGLC
BOATS
BOATS
BGLC.BOATS

0 Comments

Share your thoughts

FAQ

What is BioNexus Gene Lab stock price today?▼
The current price of BGLC is $1.57 USD — it has increased by +1.95% in the past 24 hours. Watch BioNexus Gene Lab stock price performance more closely on the chart.
What is BioNexus Gene Lab stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange BioNexus Gene Lab stocks are traded under the ticker BGLC.
Is BioNexus Gene Lab stock price growing?▼
BGLC stock has fallen by -4.27% compared to the previous week, the month change is a -5.99% fall, over the last year BioNexus Gene Lab has showed a -70.54% decrease.
What is BioNexus Gene Lab market cap?▼
Today BioNexus Gene Lab has the market capitalization of 3.8M
What were BioNexus Gene Lab earnings last quarter?▼
BGLC earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioNexus Gene Lab revenue for the last year?▼
BioNexus Gene Lab revenue for the last year amounts to 7.43M USD.
What is BioNexus Gene Lab net income for the last year?▼
BGLC net income for the last year is -2.99M USD.
How many employees does BioNexus Gene Lab have?▼
As of August 20, 2026, the company has 1 employees.
In which sector is BioNexus Gene Lab located?▼
BioNexus Gene Lab operates in the Manufacturing sector.
When did BioNexus Gene Lab complete a stock split?▼
The last stock split for BioNexus Gene Lab was on April 07, 2025 with a ratio of 1:10.
Where is BioNexus Gene Lab headquartered?▼
BioNexus Gene Lab is headquartered in KUALA LUMPUR, Malaysia.